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A B S T R A C T
The aim of this study was to investigate the prevalence of hospitalized patients of
sarcoidosis in the Republic of Croatia, its distribution in relation to sex and age as well
as its geographical distribution. The data on sarcoidosis patients hospitalized in Cro-
atia in the last six years, from 1997 to 2002, were analyzed retrospectively. The pre-
valence of sarcoidosis patients hospitalised in the Republic of Croatia is 4.1/100,000.
The prevalence among women is 4.7 and among men 3.5 per 100,000 persons, with a
ratio of 1.4:1. The disease more frequently occurs in the regions with a continental cli-
mate than in the Mediterranean zone. The ratio of sarcoidosis patients in the continen-
tal zone to the Mediterranean zone is 1.5:1. It occurs predominantly among the adults.
Over the investigated period, in our country we have not registered any case of sarcoi-
dosis among children. It occurs more frequently at a younger age and therefore 44.5% of
the patients with sarcoidosis were between 20 and 39 years of age, 40.1% were between
40 and 59 years of age and 15.3% were more than 60 years old.
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Introduction
Sarcoidosis is a systemic granuloma-
tous disease of unknown cause. It is cha-
racterized by the accumulation of CD4+
T-lymphocytes, which causes Th-1 immu-
ne response in the affected organs and
tissues. Most frequently it occurs in lungs,
lymphonodes, liver, skin and eyes, but
also in the other organs1. Acute forms of
sarcoidosis generally spontaneously re-
gress and have a good prognosis, whereas
its chronic forms are progressive with a
poor prognosis2.
The ethiology of sarcoidosis is still un-
known. There are several theories on the
causes of the disease. Nowadays it is con-
sidered that in genetically predisposed
people, one or more microorganisms that
act in a non-infectious way cause a sar-
coid granulomatous response3.
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Sarcoidosis occurs all around the world
and among all races, but with a variable
prevalence. It is more frequent in the
north than in the south. In the United
States, the disease occurs more often
among the African Americans and Puerto
Ricans than other groups. Furthermore,
it is more frequent among the Irish than
the English4.
Sarcoidosis occurs among both sexes
all around the world, predominantly among
adults, most frequently between 20 and
40 years of age5. It is more frequent among
women than men; according to the AC-
CESS study carried out in the United
States on 736 patients the ratio is 1.7:16.
Patients and Methods
The data of the Department of Health
Statistics of the Croatian Institute for
Public Health, registered in the hospital
Patient Statistical Forms under diagno-
sis D86 (which is the code for sarcoidosis
according to the 10th revision of Inter-
national Classification of Diseases ICD-10)
in the period from 1997 to the end of
2002, were analysed retrospectively. The
system of registration of hospitalised pa-
tients is run under ICD-10 codes from
year 1995. We validated the system through
checking the number of diagnosed pa-
tients in our hospital with the number of
patients registered with the ICD-10 code
D86 in the Department of Health Sta-
tistics for last three years and it shows
99.65% accuracy (288 diagnosed sarcoi-
dosis patients vs. 289 registered with
D86 ICD-10 code). The number of hos-
pitalised patients was analysed according
to age, sex and the distribution in the
counties of the Republic of Croatia. The
sex and age standardized prevalence ra-
tio was calculated according to popula-
tion data gathered from the National
population survey from the year 2001.
Odds ratios and 95% confidence intervals
were calculated by OpenEpi (version 0.99,
Andrew G. Dean and Kevin M. Sullivan,
Atlanta, GA, USA). Statistical significan-
ce was assumed for p<0.05.
Results
General prevalence
According to the data of the Depart-
ment of Health Statistics of the Croatian
Institute for Public Health, 1196 patients
were discharged from hospital with a dia-
gnosis of sarcoidosis in the period from
1997 to the end of 2002. From the data of
the Department of Statistics it was not
evident how many times the patients
were hospitalised. On average two hun-
dred patients per year were treated for
sarcoidosis in Croatian hospitals. The
prevalence of hospitalised patients is 4.1/
100,000 in total.
Geographical distribution
Sarcoidosis is not equally distributed
among the population. There are differ-
ences in its occurrence. Among the pa-
tients treated in the Croatian hospitals
the standardized prevalence was the high-
est in the County of Po`ega and Slavonija
(8.1/100,000) followed by city of Zagreb
(6.9/100,000), the County of Me|imurje
(6.3/100,000) and the County of Virovitica
and Podravina (5.1/100,000) (black in Fi-
gure 1). The lowest prevalence was in the
County of Vukovar and Srijem (2.3/
100,000) followed by counties Primorsko-
Goranska (2.5/100,000), Istarska (2.5/
100,000) and [ibenik and Knin (2.7/
100,000) (white in Figure 1). More pa-
tients affected with the disease came
from the regions with a continental cli-
mate than with a Mediterranean climate.
In the zone with a continental climate,
which has about three million inhabit-
ants, sarcoidosis was diagnosed on avera-
ge in 155 persons per year (4.6/100,000).
In the zone with a Mediteranean climate,
which about 1.4 million inhabitants, the
disease is diagnosed in 45 persons per
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year (3.0/100,000; odds ratio OR, 1.54;
95% confidence interval CI, 1.34–1.77;
p<0.001).
Prevalence by sex and age
Among 1,196 patients affected by sar-
coidosis there were 693 females and 503
males. The prevalence among women was
4.7/100,000 and among men 3.5/100,000
persons/year (OR=1.36; 95% CI=1.21–1.54;
p<0.001; Figure 2).
In Croatia there were no cases of a
diagnosed sarcoidosis in persons till the
age of 19 years. 533 saircoidosis patients
were between 20 and 39 years of age
(44.5%), among them 313 women (7.4/
100,000) and 220 men (5.9/100,000). 480
saircoidosis patients were between 40
and 59 years of age (40.1%), among them
280 women (8.7/100,000) and 200 men
(4.5/100,000); and 183 persons were older
than 60 years (15.3%), among them 100
women (1.9/100,000) and 83 men (2.8/
100,000; Figure 3).
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Fig. 2. The number of persons affected by sar-
coidosis by sex and year of diagnosis in the pe-



























Fig. 3. The number of sarcoidosis patients by
age and sex.
Discussion
Sarcoidosis is a systemic disease of
unknown etiology. Formerly it was con-
sidered as a rare disease, but numerous
epidemiological studies from all over the
world provide evidence that it is signi-
ficantly more frequent than previously
thought. The most probable reason for
such findings lies in a better knowledge
about the disease and in more accurate
methods of detection. It occurs all around
the world and among all races, but with a
variable incidence and prevalence.
Epidemiological studies provide evi-
dence that sarcoidosis is more frequent in
the north than in the south. In Sweden
the prevalence is 64, in Denmark about
20, in Finland 27/100,000 persons, where-
as it is much lower in the countries lo-
cated in the south. Thus, in Italy the
prevalence is 0.5 and in Spain it is 1.4/
100,000 persons. In the eastern Euro-
pean countries such as Poland the pre-
valence is 1.3, in the Czech Republic it is
3.5 and in Japan 1/100,000. The preva-
lence in Hungary is 4.3, in Germany 12
and in Greece 7/100,000 persons7 (Table 1).
Prevalence also varies according to ra-
ces and nations. Among African Ame-
ricans it is higher than 50/100,000 where-
as the prevalence among Puerto Ricans
who live in America is between 30–40/
100,000. Among the Caucasians in Ame-
rica the prevalence is 6.1/100,000. In
Great Britain it is 27/100,000 among men
and women. However, the prevalence
among Irish women living in London is
215 and among Irish men 97/100,0008.
According to the data from 1985, the
prevalence of sarcoidosis in countries of
ex-Yugoslavia was 2.5–3/100,000. The data
available from the European Congress on
Sarcoidosis held in Novi Sad in 1980 sta-
te the incidence in Vojvodina was 3 and in
Slovenia 7/100,000. The data on preva-
lence of sarcoidosis in Croatia dates back
to 1974 and it was then 4.15/100,000.
Since that period there were no data pub-
lished on the prevalence of sarcoidosis in
Croatia9. The only recent data, which we
had up to now, refer to Dalmatia (south
Croatia) where incidence varies between
2–3/100,00010.
Analysing the data issued by the De-
partment of Statistics of the Croatian In-
stitute for Public Health in the last six
years, we calculated the prevalence of
hospitalised patients in Croatia as 4.1/
100,000. Among women it was 4.7/100,000
and among men 3.5/100,000, with the OR
being 1.36. The ratio of prevalence be-
tween women and men in Spain is 2:1, in
Japan 3:1 and in the US, where the sam-
ple is the largest; the ratio is 1.7:1. In
Great Britain and Germany there were
no differences in prevalence between men
and women11.
In Croatia, the counties with a con-
tinental climate have a higher prevalence
than those situated in the south (OR
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TABLE 1























1.54). These data are in accordance with
the statement that sarcoidosis is more
frequent in the northern regions. There-
fore continental Croatia has prevalence
similar to Hungary and Mediterranean
Croatia to Spain.
Sarcoidosis is the disease of adults, al-
though there is evidence that children
can be affected, most often between 9 and
15 years of age with an incidence of 2.2–
2.7/1,000,000. For example, there is a re-
port in literature on a two-month-old child
suffering from sarcoidosis. In the US it is
more frequent among the children of Afri-
can Americans; in London among the
children whose parents are of Indian de-
scent and in Japan among the children
whose parents come from the other Asian
countries12. In Croatia, in the investiga-
ted period (1997–2002), no cases of sar-
coidosis among children were diagnosed.
Among adults the disease is more fre-
quent between 20 and 40 years of age13.
This corresponds with our data which,
also show the highest prevalence of sar-
coidosis in patients at the age between 20
and 40 (44.5%, 6.63/100,000).
Sarcoidosis is the disease that has
been diagnosed more often in the last
decades. Through epidemiological studies
we cannot identify its cause but they can
help us by giving us the guidelines for our
further research and for future health-
care planning.
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PREVALENCIJA HOSPITALIZIRANIH BOLESNIKA SA
SARKOIDOZOM U HRVATSKOJ
S A @ E T A K
Cilj ovog ~lanka je prikazati prevalenciju hospitaliziranih bolesnika sa sarkoidozom
u Republici Hrvatskoj, spolnu i dobnu raspodjelu oboljelih i regionalnu zastupljenost.
Retrospektivno su obra|eni podaci oboljelih od sarkoidoze hospitaliziranih u Hrvatskoj
zadnjih {est godina, od 1997. do 2002. Prevalencija hospitaliziranih bolesnika u Repu-
blici Hrvatskoj oboljelih od sarkoidoze je 4.1/100.000. Prevalencija je u `ena 4.7, a u
mu{karaca 3.5 na 100.000 osoba, u omjeru od 1.4:1. Bolest se ~e{}e javlja u podru~jima
kontinentalne klime nego u mediteranskom pojasu. Odnos oboljelih u kontinentalnom
podru~ju prema mediteranskom je 1.5:1. Prete`no se javlja kod odraslih, a u na{oj ze-
mlji u ispitivanom razdoblju nije zabilje`en niti jedan slu~aj sarkoidoze kod djece.
^e{}e se javlja kod mla|ih odraslih osoba pa je tako 44,5% bolesnika u kojih je dija-
gnosticirana sarkoidoza bilo u dobi izme|u 20–39 godina, 40,1% je u dobi od 40 do 59
godina, a 15,3% bilo je starijih od 60 godina.
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